Bloonics was established in 2016 to both end the harmful criminalization of medical cannabis users, and advance cannabinoid science. We are developing the first system to detect impairment, looking beyond the mere presence of a molecule and providing meaningful context for our users. Learn more at www.bloonics.com
关于我们
LumaCell (fka Bloonics) is developing diagnostic solutions enabling the personalization of treatment with a wide array of available therapeutics. The company has a proprietary bio-sensing platform which leverages the economics and scalability of bakers yeast to deploy functional assays in high demand applications. The current focus is on developing cannabinoid, opioid, and incretin biosensors with application in drug of abuse testing, pain management, and metabolic health.
- 网站
-
https://www.lumacell.ai
LumaCell Systems的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 类型
- 私人持股
- 创立
- 2016